<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT01668810</url>
  </required_header>
  <id_info>
    <org_study_id>RISSCH4255</org_study_id>
    <nct_id>NCT01668810</nct_id>
  </id_info>
  <brief_title>The Third Survey of Prescription Pattern of Psychotropic Drugs in China</brief_title>
  <official_title>The Third Survey on China Psychotropic Prescription for Schizophrenia, Depression and Bipolar Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Xian-Janssen Pharmaceutical Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Peking University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aimed to examine the psychotropic prescription pattern in China.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">July 2013</completion_date>
  <primary_completion_date type="Anticipated">September 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>10</number_of_groups>
  <enrollment type="Anticipated">7000</enrollment>
  <condition>Prescription</condition>
  <arm_group>
    <arm_group_label>Beijing region</arm_group_label>
    <description>include six hospitals</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Guangdong Province</arm_group_label>
    <description>include 3 hospitals</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Jiangsu province</arm_group_label>
    <description>include 3 hospitals</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hebei province</arm_group_label>
    <description>include 6 hospitals</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hubei Province</arm_group_label>
    <description>include 7 hospitals</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Shanxi province</arm_group_label>
    <description>include 3 hospitals</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Jiangxi province</arm_group_label>
    <description>include 3 hospitals</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Jilin province</arm_group_label>
    <description>include 6 hospitals</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sichuan province</arm_group_label>
    <description>include 3 hospitals</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Shaanxi province</arm_group_label>
    <description>include 3 hospitals</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        schizophrenia, depression and bipolar disorder patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: aged 18-65, inpatient or outpatient, Patient must be willing and able&#xD;
        to give written informed consent,the patient suffers from schizophrenia or depression or&#xD;
        bipolar disorder -&#xD;
&#xD;
        Exclusion Criteria:aged&lt;18or aged&gt;65&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xin Yu, MD.</last_name>
    <role>Study Chair</role>
    <affiliation>Peking University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yun-Ai Su, Phd.</last_name>
    <phone>8610-82801960</phone>
    <email>suyunai@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institute of mental health, Peking University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100191</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tianmei Si, PhD.</last_name>
      <phone>8610-82801960</phone>
      <email>si.tian-mei@163.com</email>
    </contact>
    <investigator>
      <last_name>Tianmei Si, PhD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <study_first_submitted>August 16, 2012</study_first_submitted>
  <study_first_submitted_qc>August 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 20, 2012</study_first_posted>
  <last_update_submitted>August 17, 2012</last_update_submitted>
  <last_update_submitted_qc>August 17, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 20, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University</investigator_affiliation>
    <investigator_full_name>Si Tianmei</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>prescription</keyword>
  <keyword>schizophrenia</keyword>
  <keyword>depression</keyword>
  <keyword>bipolar disorder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bipolar Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT01668810
org study id: RISSCH4255
nct id: NCT01668810
lead sponsor: 
collaborator: 
has dmc: Yes
The investigators aimed to examine the psychotropic prescription pattern in China.
observational model: Ecologic or Community
time perspective: Prospective
arm group label: Beijing region
description: include six hospitals
arm group label: Guangdong Province
description: include 3 hospitals
arm group label: Jiangsu province
description: include 3 hospitals
arm group label: Hebei province
description: include 6 hospitals
arm group label: Hubei Province
description: include 7 hospitals
arm group label: Shanxi province
description: include 3 hospitals
arm group label: Jiangxi province
description: include 3 hospitals
arm group label: Jilin province
description: include 6 hospitals
arm group label: Sichuan province
description: include 3 hospitals
arm group label: Shaanxi province
description: include 3 hospitals
study pop: 
sampling method: Probability Sample
criteria: 
gender: All
minimum age: 18 Years
maximum age: 65 Years
healthy volunteers: No
last name: Xin Yu, MD.
role: Study Chair
affiliation: Peking University
last name: Yun-Ai Su, Phd.
phone: 8610-82801960
email: suyunai@gmail.com
facility: 
status: Recruiting
contact: 
investigator: 
country: China
responsible party type: Principal Investigator
investigator affiliation: Peking University
investigator full name: Si Tianmei
investigator title: Professor
mesh term: Bipolar Disorder